Yonghao Yang Jun Li Brian G Till Jun Wang Bicheng Zhang Hanping Wang Hao Huang Tiepeng Li Quanli Gao Hongle Li Zibing Wang
10.3389/fonc.2021.728253
Front Oncol
2021 Oct 29;11:728253.
pd-1 ten adverse event apatinib camrelizumab combination immunotherapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/34778042/
Case Reports
PMC8586206
34778042
Toxic Epidermal Necrolysis-Like Reaction Following Combination Therapy With Camrelizumab and Apatinib for Advanced Gallbladder Carcinoma
2021